M&A Deal Summary

AnteoTech Acquires DIAsource ImmunoAssays SA

On August 26, 2015, AnteoTech acquired medical products company DIAsource ImmunoAssays SA for 15M EUR

Acquisition Highlights
  • This is AnteoTech’s 1st transaction in the Medical Products sector.
  • This is AnteoTech’s 0th largest (disclosed) transaction.
  • This is AnteoTech’s 1st transaction in Belgium.
Investment Fate
  • DIAsource ImmunoAssays SA was divested to a consortium of strategic buyers in 2017.

M&A Deal Summary

Date 2015-08-26
Target DIAsource ImmunoAssays SA
Sector Medical Products
Buyer(s) AnteoTech
Deal Type Add-on Acquisition
Deal Value 15M EUR

Target

DIAsource ImmunoAssays SA

Louvain-La-Neuve, Belgium
DIAsource ImmunoAssays SA is a diagnostics company that develops, manufactures, markets and distributes clinical diagnostics products in the fields of endocrinology, especially bone metabolism, fertility, cardiovascular and oncology.

Search 197,968 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

AnteoTech

Eight Mile Plains, Australia

Category Company
Founded 1995
Sector Medical Products
Employees21
Revenue 12M AUD (2016)
DESCRIPTION

AnteoTech is a developer of commercialises products for the life sciences, in-vitro diagnostics, point of care, medical devices market. AnteoTech was founded in 1995 and is based in Eight Mile Plains, Australia.


DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Belgium) 1 of 1
Year (2015) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-10-10 DIAsource ImmunoAssays SA

Louvain-La-Neuve, Belgium

DIAsource ImmunoAssays SA is a diagnostics company that develops, manufactures, markets and distributes clinical diagnostics products in the fields of endocrinology, especially bone metabolism, fertility, cardiovascular and oncology.

Sell -